1198
BACKGROUND : A previous randomized controlled trial evaluating the use of spironolactone in heart failure patients reported a low risk of hyperkalemia ( 2 % ) and renal insufficiency ( 0 % ) .
 Chemical: spironolactone; Disease: heart failure; Disease: hyperkalemia; Disease: renal insufficiency
Given options, please tell me the categories of all the listed entity words.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
 Entities: spironolactone, heart failure, hyperkalemia, renal insufficiency 
Answer:
 Chemical: spironolactone; Disease: heart failure; Disease: hyperkalemia; Disease: renal insufficiency